REGN7041
R7041-NIU-24123
Phase 2 small_molecule active
Quick answer
REGN7041 for Active Noninfectious Uveitis Affecting the Posterior Segment is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Active Noninfectious Uveitis Affecting the Posterior Segment
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active